Jane Rubenstein

Internal Medicine
717 S Houston Ave Ste 304
Tulsa, OK 74127

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1 publications

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications.

Assessing Patient Risk, Benefit, and Outcomes in Drug Development: Insights From Afatinib Clinical Trials Across Diverse Cancer Indications.

Journal: Clinical therapeutics
Published: September 11, 2023
Showing 1-1 of 1

Last Updated: 09/26/2026